The results obtained by probiotic supplementation are a function of the action of live microorganisms on the very complex population of microorganisms in the gut. The outcome of this extremely complicated interaction is bound to be subject to variation and can be influenced by several factors relating to the product, the administrator and the consumer. If we can define the reasons for these inconsistencies we will be better able to develop improved preparations which when given at the right time and in the right way will give the expected response.
Introduction
The word probiotic can mean different things to different people and the use of preparations which I do not consider to be probiotics tends to complicate the objective assessment of their value. So let us define probiotics. In 1989 I proposed the following definition: "live microbial feed supplements which beneficially affect the host by improving its intestinal microbial balance" (Fuller, 1989) . This definition embraces preparations designed to have probiotic effects and also the so called "functional foods" containing viable bacteria which are primarily nutritional aids but which have an incidental health benefit. These latter include the fermented milks.
It is difficult to say much more than this but I have recently (Fuller, 2004) suggested what I think is a useful update to include some other facets of the concept. It reads: A probiotic is a preparation of viable microorganisms which is consumed by humans and other animals with the aim of inducing beneficial effects by quantitatively or qualitatively influencing their gut flora and/or modifying their immune status.
This definition continues to emphasise the viability and the role of the gut flora. It refers to "beneficial effects" rather than "effects on health" which I think is too narrow. It also contains reference to the immunomodulating effects which are now well established (see, Fuller & Perdigon, 2000) .
That gut flora studies are so difficult to control is not difficult to understand when we consider how complex the flora is and how many factors are involved in controlling its composition and activity. As well as environment and diet the flora can be affected by host derived and microbe derived influences.
One of the problems about getting probiotics accepted is the apparent variability of the results obtained. I say "apparent" because, if we look at the way probiotics are prepared and used we can frequently explain the inconsistencies observed. It is true that we do get positive and negative results and this sometimes even happens with what appears to be identical preparations. It is this sort of information that is used to devalue the whole probiotic concept. But nobody can deny that probiotics do work. Many trials in farm animals and humans give statistically significant results (see, Fuller, 1997) . We must therefore accept that probiotics have the potential to do the things that are claimed for them. It follows from this that if we can control the factors which are causing the variation we will be able to obtain more consistent and less variable results.
Classification
It is essential that the buyer can be confident that what is on the label corresponds to the composition of the preparation. The development of new molecular methods should guarantee the correctness of the classification. However, some producers are still relying on identifications obtained using older methods. This is far from being an exact science. Consequently the identification of the same culture in two preparations may be different. Bifidobacteria in particular have proved to be difficult to distinguish using fermentation patterns and other phenotypic characteristics.
The development of new techniques of bacterial taxonomy brings with it the problem of back refer- Several studies have shown that the information given on product labels is sometimes incorrect (Hamilton-Miller et al., 1999) . Not only are they wrong at the species level but they may also contain different genera. This usually includes species related to the probiotic organisms but in the worst case they could be unrelated species which colonise the gut and produce adverse effects.
Variation of bacteria can also occur at the strain level. Two species given the same species name can vary with respect to structure, biochemical composition and metabolic activity. So that positive results using one strain of, say L. casei, need not necessarily apply to all other products containing this species. An extreme illustration of this phenomenon is the use of non-pathogenic variants of pathogenic species to protect chickens against Salmonella typhimurium and to protect hamsters (as a human model) against Clostridium difficile which is responsible for antibiotic-related diarrhoea.
Viability
By definition probiotic bacteria must be viable. How many viable bacteria are required to produce the desired affect is difficult to say; it will depend on the species contained in the probiotic and will vary according to which animal species is being treated. So it is not possible at present to state a minimum viability requirement. All that can be done is to ensure that the viability count is high.
Measurement of viability is important at the point of production, at the time of sale and after specified period of storage to give some indication of shelf life. But, of course, this cannot be absolute because shelf life will be affected by the conditions of storage after sale.
Executing the viable count is not normally a problem. However, a probiotic containing more than one species of the same genus can present difficulties. There is also a problem when the product contains a subdominant component. If selective media are used, these will only differentiate between two organisms with different susceptibilities to the selective agent. This is unlikely to be successful in separating two closely related species, such as two species of lactobacilli which often occur in the same probiotic product. There is also the danger that the selective agent will partially suppress the organism being selected for. With the new molecular techniques this will cease to be a problem. However, these are not yet standard practice with all probiotic producers.
The conditions under which probiotic bacteria have to survive after sale are very varied. Animal probiotics used in the field may have to endure sub zero temperatures in northern Europe and temperatures of over 40
• C in the tropics. There will also be a wide range of humidities throughout the world. The survival of probiotic cultures can be maximised by providing then as dried cultures in small sealed sachets in a vacuum or nitrogen atmosphere. Sachets can then be kept in cold storage and only sufficient for immediate use taken into the field.
Liquid suspensions may colonise the gut more quickly but they are more expensive to transport and have shorter shelf life.
Viability testing does not necessarily tell us anything about the ability of the organism to regenerate and initiate metabolic activity in the gut after it is ingested. The bifidobacteria are a good example of this since they are difficult to grow under in vitro conditions but are one of the most successful colonisers of the gut.
Probiotic bacteria will remain viable in the gut but will not usually colonise it permanently. Analysis of the gut flora over a period of several months showed that even indigenous strains did not persist and were rapidly replaced by others. Just occasionally the same strain was recoverable for twelve months (McCartney et al., 1996) . Perhaps this is the perfect probiotic organism; the reasons for its persistence in the gut might tell us a great deal about the selection of strains for inclusion in probiotic products.
In cattle yeasts which cannot grow in the anaerobic environment of the rumen can still affect its flora by persisting and metabolising for about six hours. Viability is essential and the effect cannot be reproduced using dead cells or yeast extract. In situations like this, in order to get the maximum response, the probiotic must contain large numbers of viable cells and be given continuously.
Immunomodulation can also be influenced by the viability of the stimulating organism (Galdeano & Perdigon, 2004) . The reason for this is not known but to speculate it may be the only way of ensuring that a sufficiently strong antigenic stimulus is generated. Translocation of live organisms which then multiply in other organs such as the spleen may also be necessary to induce a systemic response. Locally produced IgA will decrease bacterial translocation but the increase in immune cells created during the inflammatory response has been shown to enhance gut permeability. Obviously, the importance of translocation in the generation of the immune response is a very complex phenomenon and has yet to be fully explained.
Various workers have assessed the viability of commercial products and have found it to be extremely variable ranging from products which contained as many viable cells as was claimed on the label to those which contained none. Because of the importance of viability in the successful manifestation of the probiotic effect, it is essential that the viability of all preparations used in experimental trials is checked and recorded when results are published; this is seldom done. Poor viability may account for some of the negative results obtained but without the relevant data it is impossible to know.
Production conditions
The effectiveness of probiotics can be influenced by the choice of strain and the conditions under which they are produced. The composition of the growth medium is very important and will affect the yield as well as the characteristics of the harvested cells. A compromise has to be reached between keeping the cost of the medium down and producing the maximum concentration of viable cells in the shortest possible time.
Growth temperature and gaseous environment can affect the type and number of cells produced. The product may also be affected by the point in the organisms growth cycle at which the cells harvested. Organisms from the log phase may behave differently than those from the stationary phase of growth. Changes of this sort could account for differences observed in response between two batches of the same probiotic.
The source of the inoculum for commercial production should also be kept constant. There should always be freeze dried stock culture which provides the inoculum for successive batch. There should never be serial transfer from one batch to the next.
The way in which the final product is presented to the consumer may vary. It may be prepared as paste, tablets, capsules, powders or granules or as suspensions in water, oil or milk. At all stages the environment should be controlled with respect to humidity and temperature. Exposure to unfavourable environmental conditions during processing may have a permanent affect on viability which cannot be reversed by subsequent return to optimal conditions (Lauland, 1994) .
The pressures and shearing forces experienced during tablet formation can affect viability as can the dwell time and the shape of the punches used. Viability is better preserved in the form of powders, granules and capsules. Capsulation can be used to control the point of release in the gut. The use of an excipient which is also a nutrient will encourage recovery and growth after the dried cells have been released from the capsule.
Selection of the strain to be used based on in vitro tests may also help to ensure successful survival in the gut and a good probiotic response. Some features which may be useful in this respect are: (i) ability to resist antibacterial factors in the gut; (ii) rapid growth rate; (iii) ability to attach to gut epithelial cells; and (iv) production of antibacterial agents.
This sort of in vitro derived information should be used with caution; it is very probable that what was detectable under in vitro conditions will not apply under the conditions which obtain in the gut.
Whatever precautions are taken to maximise the viability of the product, it should be remembered that it is being given by mouth and, therefore, it must not have an offensive odour or taste. In this context fermented milks have a great advantage because they are also considered by the consumer to be food. Probiotic bacteria have also been included in other foods such as cheese, fruit drinks and confectionary.
Method of administration
The way in which a probiotic is given to a consumer (human or farm animal) will affect the outcome. We do not know what the minimum effective dose is so it is as well to make sure that the dose is adequate by giving large amounts continuously. Published trials have used single, multiple and continuous dosing. Often the results obtained with these different regimes have been compared and, not surprisingly, found to have given different results.
Probiotics can be administered directly into the mouth as tablets, capsules or powders or they may be included in diet or water. Addition to water can have its problems due to osmotic shock or if tap water is used to bactericidal effect of chlorine.
Probiotic organisms do not normally colonise the gut permanently, nor do we know how long they survive or how long the probiotic effect lasts after dosing ceases. This will depend on the type of probiotic being used, the frequency of administration and the animal species receiving the dose.
Probiotics should be regarded as prophylactic rather than therapeutic and should, therefore, be given before symptoms appear. This is common practice with farm animals where the probiotic is included routinely in the feed and a case can be made for their regular cosumption by humans. The current move towards marketing probiotics in foodstuffs such as fermented milks may help to achieve this.
State of the gut flora
If we accept that the probiotic is having its effect by improving the intestinal microbial balance, then in order for a probiotic to be effective there must be an imbalance; this is not always the case. In some ways the response of farm animals to probiotics is similar to the antibiotic response which is obtained by reversing the growth depressing effect of bacteria in the gut. It has been shown that if the growth depressing organism is not present in the gut, there will be no improvement in growth when the antibiotic is included in the diet. The type of housing or accommodation will affect the result because it is providing a different environmental flora. In the case of chickens it was shown that if they were reared in clean fumigated rooms they showed no response because they had not been exposed to the growth depressing organism.
Similarly if the human consumers of probiotics have been maintained under optimal conditions the imbalance may not be present and there will be no effect. On the other hand, the gut flora may be too complete and not deficient in the organisms which the probiotic is designed to provide. For example, in human infants it has been observed that the bifidobacterium flora can vary not only between countries but also between urban and rural areas of the same country and even between wards of the same hospital. The lactobacillus flora of the human gut also shows differences between countries. This sort of variation in the gut flora could mean that the beneficial probiotic bacteria are already present. Consequently there will be no scope for a positive probiotic effect.
The effect of diet may also be important (Satokari et al, 2002 ). The differences between formula feeding and breast feeding have been highlighted in the past but recent work suggests that the differences are not as great at was at first thought. But there may still be differences in the responses obtained with breast and formula fed babies. Weaning may also produce changes in the gut flora which will influence the response to probiotic supplementation.
